Evaxion A (EVAX) EV to EBIT (2021 - 2026)

Evaxion A (EVAX) EV to EBIT (2021 - 2026) Analysis & Trends

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	EV to EBIT
1	Oculis Holding AG	66,621.14 Bn	66,620.85 Bn	-	-846,807.28
2	Nanobiotix	1,915.18 Bn	1,915.11 Bn	-	-155,086.11
3	Akari Therapeutics	1,014.18 Bn	1,014.18 Bn	-	-34,369.83
4	BeOne Medicines	471.27 Bn	466.48 Bn	1.35 Bn	680.06
5	Vertex Pharmaceuticals	121.81 Bn	114.57 Bn	2.59 Bn	24.47
6	Regeneron Pharmaceuticals	69.58 Bn	60.82 Bn	3.31 Bn	16.76
7	Belite Bio	62.72 Bn	62.72 Bn	-	-3.56
8	Argenx Se	55.51 Bn	50.33 Bn	1.41 Bn	31.44
9	Revolution Medicines	37.35 Bn	37.35 Bn	-	-26.93
10	Evaxion A	1.24 Bn	1.24 Bn	-	-135.46

Download Data